Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Document › Details

Oncopeptides AB. (5/6/20). "Press Release: Oncopeptides Has Completed a Directed Share Issue Raising approximately SEK 1,414 Million (USD 144 M) [NOT FOR US, AU, CA, et al.]". Boston, MA.

	Organisation	Oncopeptides AB (Nasdaq Stockholm: ONCO)
	Group	Oncopeptides (Group)
	Organisation 2	Deerfield (Group)
	Product	Melflufen
	Product 2	investment banking
	Index term	Oncopeptides–SEVERAL: investment, 202005 directed share issue SEK1.414b ($144m) with 12.295m new shares at SEK115/share
	Person	Lindberg, Jakob (Oncopeptides AB 202301 CSO before CEO)
	Person 2	Piir, Rein (Oncopeptides 201912 Head of Investor Relations)

Original document
accessed by [iito] on 2020-05-15

Record changed: 2023-06-05

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for Oncopeptides (Group)

[1] Oncopeptides AB. (3/8/23). "Press Release: Oncopeptides CSO Investigated for Violation of the Market Abuse Act"....
[2] Oncopeptides AB. (1/11/23). "Press Release: Oncopeptides Appoints Holger Lembrer as Chief Financial Officer". Stockholm....
[3] Oncopeptides AB. (1/4/23). "Press Release: Monica Shaw Appointed CEO of Oncopeptides – Jakob Lindberg Assumes Position as Chief Scientific Officer". Stockholm....
[4] Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm....
[5] Shorla Pharma Ltd.. (3/2/21). "Press Release: Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer". Clonmel....
[6] Oncopeptides AB. (2/26/21). "Press Release: FDA Approves Oncopeptides' Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma". Stockholm....
[7] Oncopeptides AB. (10/14/20). "Press Release: Oncopeptides Signs € 40 Million Loan Agreement with the EIB". Stockholm....
[8] Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm....
[9] Oncopeptides AB. (6/28/19). "Press Release: Oncopeptides Has Completed a Directed Share Issue of approximately SEK 727 Million (USD 78 M) [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]"....
[10] Oncopeptides AB. (6/27/19). "Press Release: Oncopeptides Intends to Make a Directed Share Issue [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]